Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nirogacestat in Ovarian Granulosa Cell Tumors
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Summary
This phase 2 clinical trial will study the effectiveness of nirogacestat in ovarian granulosa cell tumors (OvGCTs). Nirogacestat is a gamma secretase inhibitor (GSI) which is hypothesized to decrease the growth and activity of ovarian granulosa tumors.
Official title: A Phase 2 Trial of Nirogacestat in Patients With Recurrent Ovarian Granulosa Cell Tumors
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
53
Start Date
2022-08-30
Completion Date
2025-07-14
Last Updated
2026-08-25
Healthy Volunteers
No
Interventions
Nirogacestat
nirogacestat oral tablet
Locations (21)
USC/Norris Comprehensive Cancer Center
Los Angeles, California, United States
UCLA-JCCC Dept. of OBGYN - Women's Health Clinical Research Unit
Los Angeles, California, United States
AdventHealth Orlando
Orlando, Florida, United States
Orlando Health Cancer Institute
Orlando, Florida, United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Women's Cancer Care
Covington, Louisiana, United States
Greater Baltimore Medical Center
Baltimore, Maryland, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
David C. Pratt Cancer Center
St Louis, Missouri, United States
University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico, United States
Columbia University Medical Center
New York, New York, United States
Memorial Sloan Kettering Cancer Institute
New York, New York, United States
Women's Cancer Center at Kettering
Kettering, Ohio, United States
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
UW/Fred Hutch Cancer Center
Seattle, Washington, United States
Froedtert and Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Cross Cancer Institute
Edmonton, Alberta, Canada
Maria Sklodowska-Curie Bialystok Oncology Center
Bialystok, Poland
Jagiellonian Innovation Centre Clinical Research Centre
Krakow, Poland
University Teaching Hospital Poznan, Department of Oncological Gynaecology
Poznan, Poland
Maria Sklodowska-Curie National Institute of Oncology-National Research Institute, Clinic of Oncological Gynecology
Warsaw, Poland